Three Oruka insiders (CEO, COO, SVP Finance) sold a combined $375,574.92 in open-market sales on 2026-09-15. The cluster is small relative to the company's $6.4B market cap (~0.006%), making it immaterial from a dollar-value perspective. All three sales occurred on the same date at the same price, consistent with a shared blackout-window opening or vesting event rather than a coordinated bearish signal. Per the asymmetric calibration, cluster sells are not amplified, and the dollar value is trivial relative to company size.
ORKA drugs
ORKA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 16 $93.55entry
- T+1 · 2mo ago +4.47%α +3.33% · $97.73
- T+5 · 8w ago −3.87%α −6.44% · $89.93
- T+20 · 5w ago −16.42%α −19.60% · $78.19
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
How similar events traded
Executive Summary
Three Oruka insiders (CEO, COO, SVP Finance) sold a combined $375,574.92 in open-market sales on 2026-09-15. The cluster is small relative to the company's $6.4B market cap (~0.006%), making it immaterial from a dollar-value perspective. All three sales occurred on the same date at the same price, consistent with a shared blackout-window opening or vesting event rather than a coordinated bearish signal. Per the asymmetric calibration, cluster sells are not amplified, and the dollar value is trivial relative to company size.
Key Financial Metrics
Financial Impact
Not specified
Risk Factors
- Insider sales cluster on a single date may indicate a shared liquidity event (vesting, blackout window) rather than fundamental deterioration.
- The cluster is immaterial relative to market cap (<0.1%), limiting its predictive value.
- Pharmaceutical sector volatility could amplify any negative reaction to perceived insider pessimism.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1789514294477 |
Track record
40 reports on ORKA
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers